Induction (Ind) plus concurrent (Con) chemotherapy with high-dose (74 Gy) 3-dimensional (3-D) thoracic radiotherapy (TRT) in stage III non-small cell lung cancer (NSCLC): Preliminary report of Cancer and Leukemia Group B (CALGB) 30105 Blackstock, A. W. , Socinski, M. A. , Bogart, J. , Gu, L. , Wang, X. ... - - J. Clin. Oncol. - 2006 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30105
Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153. Blum, Kristie A , Johnson, Jeffrey L , Niedzwiecki, Donna ... - - Cancer - 2006 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Lymphoma - CALGB-9153
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. Cornett, Wendy R , McCall, Linda M , Petersen, Rebecca P ... - - J. Clin. Oncol. - 2006 Manuscript - Primary Endpoint - Primary Analysis - Experimental - Z0020
Eicosanoid modulation in advanced non-small cell lung cancer (NSCLC): CALGB 30203 Edelman, M. J. , Watson, D. M. , Wang, X. , Kratzke, R. A. ... - - J. Clin. Oncol. - 2006 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30203
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Kemeny, Nancy E , Niedzwiecki, Donna , Hollis, Donna R ... - - J. Clin. Oncol. - 2006 Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-9481
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). Lichtman, Stuart M , Hollis, Donna , Miller, Antonius A ... - - J. Clin. Oncol. - 2006 Manuscript - Primary Endpoint - Primary Analysis - Experimental - CALGB-9762
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Meyerhardt, Jeffrey A , Heseltine, Denise , Niedzwiecki, Donna ... - - J. Clin. Oncol. - 2006 Manuscript - Secondary Endpoint - Primary Analysis - Prevention - CALGB-89803
Bortezomib and Pegylated Liposomal Doxorubicin as Induction Therapy for Adult Patients with Symptomatic Multiple Myeloma: Cancer and Leukemia Group B Study 10301 Orlowski, R. Z. , Peterson, B. L. , Sanford, B. , Chanan-Khan, A. A. ... - ASH - ASH Annual Meeting Abstracts - 2006 Abstract - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10301
Long term efficacy of peripheral androgen blockade on prostate cancer: CALGB 9782. Picus, J. , Halabi, S. , Small, E. , Hussain, A. , Philips, G. ... - - J. Clin. Oncol. - 2006 Abstract - Primary Endpoint - Primary Analysis - GU - CALGB-9782
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Schild, Steven E , McGinnis, William L , Graham, David ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2006 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0028
Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results Venook, A. , Niedzwiecki, D. , Hollis, D. , Sutherland, S. ... - ASCO - J. Clin. Oncol. - 2006 Abstract - Primary Endpoint - Preliminary Analysis - GI - CALGB-80203
Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. Wallace, Kris , Fleshner, Neil , Jewett, Michael , Basiuk, Joan ... - - J. Clin. Oncol. - 2006 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GU - Z0070
